DB17215ExperimentalProtein Based Therapies
SBT-100 is an anti-signal transducer and activator of transcription 3 (STAT3) B VHH13 single-domain antibody (sdAb). It was granted orphan drug designation by the FDA for the treatment of pancreatic...
- Mechanism
- Curator reviewed
Pharmacologically active on Signal transducer and activator of transcription 3 and GTPase KRas
- Also known as
- anti-STAT3 B VHH13 · Anti-STAT3 B VHH13 single domain antibody
- Code names
- SBT 100
Resolves to
Targets
What you can answer from here — as of July 08, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with SBT-100, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account